Yahoo Web Search

Search results

    • Antengene To Present One Oral and Four Abstracts at ASCO 2024

      FOX 4 Kansas City· 7 hours ago

      ...", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer, today announced one oral presentation, three poster presentations and a journal publication...